XXXX due to @entity6729 . Clinical features and therapeutic response.

@entity1 @entity2261 @entity115 @entity799 @entity55 @entity2929 @entity189 @entity798 @entity3524 @entity281 @entity358 @entity580 @entity869 @entity6729 @entity803 @entity206
A study was made of the clinical features and therapeutic response of 144 @entity1 from whose sputum @entity6729 was isolated. Typically, features of @entity281 with cough productive of moderate amounts of purulent sputum, fever and dyspnoea were present. Of 74 @entity1 who were infected in the community, 50 required hospital admission. @entity580 occurred in the remaining 70 @entity1 . Most @entity1 had chronic @entity358 or @entity189 bronchus; @entity55 occurred in 12 @entity1 . Acute tracheobronchitis developed in 4 healthy non-smokers after viral illnesses. @entity6729 contributed to the death of 8 @entity1 . Overall, 59% of isolates produced beta-lactamase but the proportion had risen to 70% by the end of the study; half of these were community acquired. 41% of @entity1 who were treated initially with @entity869 did not respond. @entity798 plus @entity115 , @entity799 , @entity2929 , @entity803 , @entity2261 and @entity3524 are useful alternative antibiotics. All strains of @entity6729 were resistant to @entity206 .
